BioSpace News Archive

Drug Development

Emotional Brain’s FSIAD Products Lybrido and Lybridos Show High Efficacy and Safety in Phase IIb Trials

Emotional Brain is pleased to announce the publication of positive phase 2B results in the authoritative Journal of Sexual Medicine.

January 9, 2018
·
1 min read
Genetown

Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

The U.S. patent will not expire until after 2033.

January 9, 2018
·
1 min read
Drug Development

Novartis Advances Head-to-Head Superiority Trials of Cosentyx Versus Humira And Proposed Biosimilar Adalimumab

SURPASS and EXCEED are part of a larger rheumatology program for Cosentyx.

January 9, 2018
·
13 min read
Pharm Country

Tauriga Sciences on Track to Become Completely Free of Convertible Debt

As of today’s date, the Company reports that less than $225,000 of Face Value convertible debt remains (in aggregate).

January 9, 2018
·
3 min read
NIH Awards Longeveron Cutting-Edge Research Grant to Fight ‘Metabolic Syndrome’ of Obesity, High Blood Pressure, Unhealthy Cholesterol and More through Regenerative Medicine

The NIA recognized this, and recently awarded a prestigious research grant to Longeveron, a regenerative medicine therapy company based in Miami, Florida.

January 9, 2018
·
2 min read
Business

Human Longevity and AMRA Partner to Provide Advanced Body Composition Profiling to HLI’s Health Nucleus Clients

AMRA and Human Longevity have announced a new agreement that will see AMRA’s body composition profiling added to HLI’s premier health assessment, the Health Nucleus experience.

January 9, 2018
·
1 min read
Lone Star Bio

Aerin Launching a Novel Non-Invasive Solution for Nasal Airway Obstruction

Aerin Medical announced that it has received regulatory clearance for its novel VIVAER Non-Invasive Airway Remodeling System.

January 9, 2018
·
2 min read
Genedata Screener Raises the Bar on Automation in 2018

Genedata today announced that Genedata Screener has been enhanced towards full automation of the planning, execution, and data analysis of screening experiments.

January 9, 2018
·
3 min read
GN Store Nord: Transactions in Relation to Share Buyback Program – Jan. 9, 2018

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

January 9, 2018
·
2 min read
Drug Development

Publication Authored by Researchers at Selecta Biosciences and the National Cancer Institute in PNAS Discusses Restoration of Anti-Tumor Activity of Recombinant Immunotoxin LMB-100 When Combined With SVP-Rapamycin

In the PNAS publication, the authors described preclinical work in which SVP-Rapamycin mitigated the formation of inhibitory ADAs to LMB-100 in both naïve mice and mice pre-exposed to LMB-100, resulting in restoration of LMB-100’s anti-tumor activity.

January 9, 2018
·
5 min read